These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27163196)

  • 1. Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathway.
    Yi M; Dou F; Lu Q; Yu Z; Chen H
    Neurosci Lett; 2016 Jun; 624():62-71. PubMed ID: 27163196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted inhibition of KCa3.1 attenuates TGF-β-induced reactive astrogliosis through the Smad2/3 signaling pathway.
    Yu Z; Yu P; Chen H; Geller HM
    J Neurochem; 2014 Jul; 130(1):41-49. PubMed ID: 24606313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traumatic scratch injury in astrocytes triggers calcium influx to activate the JNK/c-Jun/AP-1 pathway and switch on GFAP expression.
    Gao K; Wang CR; Jiang F; Wong AY; Su N; Jiang JH; Chai RC; Vatcher G; Teng J; Chen J; Jiang YW; Yu AC
    Glia; 2013 Dec; 61(12):2063-77. PubMed ID: 24123203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.
    Yi M; Yu P; Lu Q; Geller HM; Yu Z; Chen H
    Mol Cell Neurosci; 2016 Oct; 76():21-32. PubMed ID: 27567685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca
    Yu Z; Dou F; Wang Y; Hou L; Chen H
    J Neuroinflammation; 2018 Nov; 15(1):316. PubMed ID: 30442153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke.
    Yi M; Wei T; Wang Y; Lu Q; Chen G; Gao X; Geller HM; Chen H; Yu Z
    J Neuroinflammation; 2017 Oct; 14(1):203. PubMed ID: 29037241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCa3.1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway.
    Wei T; Wang Y; Xu W; Liu Y; Chen H; Yu Z
    Neurobiol Dis; 2019 Dec; 132():104588. PubMed ID: 31470105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
    Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
    Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
    Chen CL; Liao JW; Hu OY; Pao LH
    Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCa3.1 Inhibition Switches the Astrocyte Phenotype during Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling Pathways.
    Yu Z; Yi M; Wei T; Gao X; Chen H
    Front Cell Neurosci; 2017; 11():319. PubMed ID: 29075181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
    Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
    Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role and mechanism of K
    Ma XZ; Pang ZD; Wang JH; Song Z; Zhao LM; Du XJ; Deng XL
    Exp Cell Res; 2018 Aug; 369(2):208-217. PubMed ID: 29792849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
    Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
    PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
    D'Alessandro G; Catalano M; Sciaccaluga M; Chece G; Cipriani R; Rosito M; Grimaldi A; Lauro C; Cantore G; Santoro A; Fioretti B; Franciolini F; Wulff H; Limatola C
    Cell Death Dis; 2013 Aug; 4(8):e773. PubMed ID: 23949222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K
    Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
    Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer's Disease.
    Wei T; Yi M; Gu W; Hou L; Lu Q; Yu Z; Chen H
    Front Pharmacol; 2016; 7():528. PubMed ID: 28105015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
    Zhang Y; Feng Y; Chen L; Zhu J
    Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
    Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
    Xie H; Lu J; Zhu Y; Meng X; Wang R
    Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.